BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records

  October 12, 2026

   · 

  19 min read
• Press Releases

  First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026

  October 12, 2026

   · 

  1 min read
• Press Releases

  Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments

  Founded by a former biotech finance professional, biosuite helps smaller biotech teams track financial commitments to research partners before the corresponding invoices arrive.

  October 12, 2026

   · 

  1 min read
• Press Releases

  Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases

  October 12, 2026

   · 

  1 min read
• Press Releases

  InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China

  October 12, 2026

   · 

  2 min read
• Press Releases

  Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer

  October 12, 2026

   · 

  8 min read
• Press Releases

  Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo®) in Patients With Mycosis Fungoides and Sézary Syndrome

  October 12, 2026

   · 

  11 min read
• Press Releases

  Concept Life Sciences Appoints Dr Adrijana Vinter as Chief Executive Officer

  October 12, 2026

   · 

  4 min read
• Press Releases

  Hankang Pharmaceutical Reaches Key Milestone in AI-Driven Small Molecule Discovery Program for Oncology and Autoimmune Diseases

  Program supported by a Tianjin Municipal Major Special Project marks Hankang’s move from development partner to originator of Class 1 innovative drugs.

  October 12, 2026

   · 

  1 min read
• 

  Manufacturing

  GSK pledges $800M to add biologics production capabilities in Pennsylvania

  Starting next year, GSK plans to demolish existing buildings and construct new facilities to support clinical and commercial supply. The investment will create more than 300 new jobs over the next five years, Pennsylvania state officials said.

  October 12, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor